CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 375 filers reported holding CRISPR THERAPEUTICS AG in Q1 2023. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,579 | +1105.3% | 34,794 | +1386.9% | 0.00% | – |
| Q2 2023 | $131 | -81.6% | 2,340 | -85.2% | 0.00% | -100.0% |
| Q1 2023 | $713 | +199.6% | 15,777 | +169.3% | 0.00% | – |
| Q4 2022 | $238 | -99.8% | 5,858 | +150.3% | 0.00% | – |
| Q3 2022 | $152,000 | +7.0% | 2,340 | 0.0% | 0.00% | – |
| Q2 2022 | $142,000 | -86.4% | 2,340 | -85.9% | 0.00% | -100.0% |
| Q1 2022 | $1,044,000 | +2.7% | 16,638 | +24.0% | 0.00% | 0.0% |
| Q4 2021 | $1,017,000 | -57.2% | 13,421 | -11.6% | 0.00% | -50.0% |
| Q3 2021 | $2,378,000 | -0.5% | 15,186 | +2.8% | 0.00% | 0.0% |
| Q2 2021 | $2,391,000 | +892.1% | 14,774 | +646.2% | 0.00% | – |
| Q1 2021 | $241,000 | -88.7% | 1,980 | -85.8% | 0.00% | -100.0% |
| Q4 2020 | $2,133,000 | +471.8% | 13,933 | +174.2% | 0.00% | +200.0% |
| Q2 2020 | $373,000 | +12333.3% | 5,082 | +5484.6% | 0.00% | – |
| Q1 2020 | $3,000 | -99.7% | 91 | -99.5% | 0.00% | -100.0% |
| Q1 2018 | $914,000 | +1328.1% | 20,015 | +623.1% | 0.04% | +1233.3% |
| Q4 2017 | $64,000 | +8.5% | 2,768 | -16.7% | 0.00% | +50.0% |
| Q3 2017 | $59,000 | – | 3,323 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $27,989,046 | 33.20% |
| Gilfoyle Management LLC | 100 | $4,842 | 15.90% |
| NEA Management Company, LLC | 1,587,854 | $89,142,124 | 6.80% |
| ARK Investment Management | 7,338,447 | $411,980,394 | 2.73% |
| Nikko Asset Management Americas, Inc. | 3,533,357 | $198,327,328 | 2.09% |
| Del-Sette Capital Management, LLC | 33,661 | $1,889,729 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Merlin Capital, Inc | 8,802 | $494,144 | 1.67% |
| Green Alpha Advisors, LLC | 34,373 | $1,929,700 | 1.27% |